Physician profile
Anna Pavlov
NPI 1821485111
$1,556.96
in general payments reported to CMS, 2019-2025
15 companies · $908 in 2025
The $908 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $122 · 2022: $474 · 2023: $52.59 · 2025: $908.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $813 · Food and Beverage: $148.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $812.50 |
| Food and Beverage | $148.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $852.25 | 2022-2025 | |
| Access Pro Medical, LLC | $217.40 | 2022 | |
| Abbvie INC. | $95.29 | 2023-2025 | |
| Mentor Worldwide LLC | $90.62 | 2021-2022 | |
| Pacira Pharmaceuticals Incorporated | $52.10 | 2022-2025 | Exparel |
| Misonix INC | $42.63 | 2021 | |
| Bioventus LLC | $42.50 | 2022 | |
| Kerecis Limited | $40.87 | 2022 | |
| Sientra, INC. | $21.49 | 2022 | |
| Novo Nordisk INC | $19.80 | 2022 | |
| Mylan Specialty L.P. | $18.63 | 2022 | |
| Integra Lifesciences Corporation | $17.77 | 2021 | |
| Motiva USA, LLC | $16.92 | 2025 | |
| Endo Pharmaceuticals INC. | $14.84 | 2021 | |
| Allergan, INC. | $13.85 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Pavlov listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.